RetiSpec platform
Hyperspectral retinal imaging AI
Combines hyperspectral imaging with AI to predict amyloid buildup associated with Alzheimer's disease from a non-invasive eye scan; company states it is for research use only.
Learn moreRetiSpec
AIDigital Health & HealthTechToronto, ON
Toronto company selling a hyperspectral retinal imaging platform that uses AI to detect Alzheimer's-related amyloid biomarkers through a non-invasive eye scan, currently for research use only.
Canadian innovation builds a brighter tomorrow.
About
Company site: retispec.comToronto company selling a hyperspectral retinal imaging platform that uses AI to detect Alzheimer's-related amyloid biomarkers through a non-invasive eye scan, currently for research use only.
RETISPEC INC. is an active federal Business Corporation with registered office in Toronto, Ontario, incorporated 2016-09-30. ised-isde.canada.ca
Closed a $10 million USD round to advance commercialization of its AI-driven eye test for Alzheimer's detection. prnewswire.com
Announced a collaboration and investment with Topcon Healthcare, Inc. to help bring the eye-based AI diagnostic tool to market; Topcon's Chief Commercial Officer Lance Patton sits on RetiSpec's board. prnewswire.com
The company states its technology is 'currently for research use only.' retispec.com
Products & Services
Company site: retispec.comProducts RetiSpec publishes on its own site. Each card links to the page it was taken from.
Funding & Investors
Announced rounds only, newest first. Undisclosed amounts are shown as undisclosed.
Growth/strategic
Jul 26, 2024
US$10.0Mprnewswire.comInvestors: Topcon Healthcare
Total disclosed: US$10.0MLatest: Growth/strategic · Jul 26, 2024
Partnerships
Publicly announced partnerships.
Topcon Healthcare, Inc.
Strategic collaboration and investment to bring RetiSpec's eye-based AI diagnostic tool to market.
Government & Grants
Government support actually received. Unpublished amounts are left out.
Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution
Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution
Canadian International Innovation Program (CIIP), Global Affairs Canada
Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution
Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada
Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada
Innovation Assistance Program, National Research Council Canada
CanExport - Innovation, Global Affairs Canada
Recent News
- Jul 26, 2024Funding
RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's Disease
RetiSpec closed a $10 million USD funding round to advance commercialization of its AI-driven, hyperspectral retinal imaging eye test for early detection of Alzheimer's disease.
- Apr 30, 2024Partnership
RetiSpec, Topcon Healthcare, Inc. Announce Collaboration, Investment to Help Bring Eye-Based AI Diagnostic Tool to Market
RetiSpec and Topcon Healthcare announced a strategic collaboration and investment aimed at bringing RetiSpec's eye-based AI diagnostic tool to market.
People
Sourced from the company's own pages or announcements.
Eliav Shaked
Chief Executive Officer & Co-founder
Roy Kirshon
Chief Operating Officer & Co-founder
Technology Focus
Company site: retispec.comTerms the company uses about its own work.
Hyperspectral imagingRetinal biomarker AIAlzheimer's detection
Similar Companies
Other companies in AI.
